Pomalyst Approval History
FDA Approved: Yes (First approved February 8, 2013)
Brand name: Pomalyst
Generic name: pomalidomide
Dosage form: Capsules
Company: Celgene Corporation
Treatment for: Multiple Myeloma
Pomalyst (pomalidomide) is a thalidomide analogue indicated for the treatment of patients with multiple myeloma.
Development History and FDA Approval Process for Pomalyst
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.